Question

I am a breastfeeding mother and i want to know if it is safe to use Dexfenfluraminum [Latin]? Is Dexfenfluraminum [Latin] safe for nursing mother and child? Does Dexfenfluraminum [Latin] extracts into breast milk? Does Dexfenfluraminum [Latin] has any long term or short term side effects on infants? Can Dexfenfluraminum [Latin] influence milk supply or can Dexfenfluraminum [Latin] decrease milk supply in lactating mothers?

Dexfenfluraminum [Latin] lactation summary

Dexfenfluraminum [Latin] is unsafe in breastfeeding
  • DrLact safety Score for Dexfenfluraminum [Latin] is 5 out of 8 which is considered Unsafe as per our analyses.
  • A safety Score of 5 indicates that usage of Dexfenfluraminum [Latin] may cause serious side effects in breastfed baby.
  • Our study of different scientific research indicates that Dexfenfluraminum [Latin] may cause moderate to high side effects or may affect milk supply in lactating mother.
  • Our suggestion is to use safer alternate options rather than using Dexfenfluraminum [Latin] .
  • It is recommended to evaluate the advantage of not breastfeeding while using Dexfenfluraminum [Latin] Vs not using Dexfenfluraminum [Latin] And continue breastfeeding.
  • While using Dexfenfluraminum [Latin] Its must to monitor child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About Dexfenfluraminum [Latin] usage in lactation

Anti-depressive drug that has been used as an anorexigenic. It is a very risky drug. No adverse effect has been described. Breastfeeding women recover their pre-pregnancy body weight sooner than bottle-feeding mothers. Withdrawn from the market in Spain.

Alternate Drugs for Antiobesity preparations. ATC A08

Orlistat(Low Risk)
Sibutramine(Unsafe)
Anfepramone(Dangerous)
Benfluorex-Hcl(Dangerous)
Ephedrine(Low Risk)
Fenfluramine(Unsafe)
Phentermine(Dangerous)
Rimonabant(Unsafe)
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.